Examination of Potassium Levels in Saliva in ESRD Patients
NCT02596386 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2015-11-04
Summary
Dialysis patients typically undergo 3 treatments a week every other day with an almost 3 day gap during the weekend. After this gap and before the first dialysis of the week the serum Potassium level is expected to be maximal.
Participants will be recruited from the dialysis clinic at Hadassah Ein Kerem Hospital. The research team would personally meet the patients who answer inclusion criteria f and ask whether they wish to participate.
Each willing participant will undergo Sialometry and blood will be drawn from the dialysis connections for CBC and Biochemistry to establish a baseline.
The study measurements namely Sialometry and collection of Saliva as well as blood test will be taken before the initiation of the dialysis.
Blood testing will be done via the laboratories of the Hadassah hospital. Saliva analysis will be done in the research lab of Prof. Doron Aframian.
Conditions
- ESRD
Interventions
- PROCEDURE
-
sialometry
potassium evaluation
- PROCEDURE
-
blood test
potassium evaluation
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Doron J Aframian, MD,PhD · Hadassah Medical Organization
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2016-11-30
- Completion
- 2017-11-30
More Related Trials
-
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
NCT03528681 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.
NCT03303521 ·Status: COMPLETED ·Phase: PHASE3
-
SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients
NCT06029179 ·Status: COMPLETED ·Phase: NA
-
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
NCT00237783 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia
NCT02875834 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia
NCT04997161 ·Status: TERMINATED ·Phase: PHASE4
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis
NCT04799067 ·Status: COMPLETED
-
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS
NCT07178964 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tissue K+ in Primary Hyperaldosteronism
NCT04251780 ·Status: COMPLETED
-
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
NCT04727528 ·Status: TERMINATED ·Phase: PHASE3
-
The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
NCT01509170 ·Status: UNKNOWN
-
A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
NCT06185660 ·Status: COMPLETED
-
Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
NCT03172702 ·Status: COMPLETED ·Phase: PHASE3
-
Spironolactone Safety in Dialysis Patients
NCT00328809 ·Status: WITHDRAWN ·Phase: PHASE4
-
Dietary Sodium Restriction in Hemodialysis Patients
NCT01896882 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
NCT04676646 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
NCT06578078 ·Status: RECRUITING ·Phase: PHASE3
-
An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure
NCT05297409 ·Status: COMPLETED
-
DIALYSATE SODIUM CONCENTRATION AND BLOOD PRESSURE IN CHRONIC HEMODIALYSIS PATIENTS
NCT06547697 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)
NCT06814132 ·Status: COMPLETED ·Phase: PHASE1
-
Potassium Intake in Patients With Chronic Kidney Disease
NCT00949585 ·Status: COMPLETED ·Phase: NA
-
Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT
NCT02778516 ·Status: COMPLETED ·Phase: NA
-
Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
NCT00276289 ·Status: COMPLETED ·Phase: NA
-
The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study
NCT05904808 ·Status: COMPLETED ·Phase: PHASE4